home / stock / ctkb / ctkb articles

CTKB Articles, Cytek Biosciences Inc.

Stock Information
Company Name: Cytek Biosciences Inc.
Stock Symbol: CTKB
Market: NASDAQ
Website: cytekbio.com
Menu
CTKB CTKB Quote CTKB Short CTKB News CTKB Articles CTKB Message Board
Get CTKB Alerts

News, Short Squeeze, Breakout and More Instantly...
Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

FREMONT, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announ...
Cytek Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates | Benzinga

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. Th...

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe | Benzinga

FREMONT, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, continues ...

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024 | Benzinga

FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today anno...
Cytek® Biosciences Names William McCombe Chief Financial Officer | Benzinga

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif....

Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday | Benzinga

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday. Shares of Tesla, Inc. (NASDAQ: TSLA) fell during Monday&rsqu...

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...
Cytek Biosciences to Participate in Upcoming Investor Conferences | Benzinga

FREMONT, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today annou...

Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries | Benzinga

FREMONT, Calif. and BARCELONA, Spain, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions...

Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

FREMONT, Calif., Dec. 28, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today annou...
Next 10